Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,071 | 261 | 96.0% |
| Education | $210.03 | 49 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $835.92 | 38 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $619.80 | 78 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $548.70 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $408.89 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $402.54 | 19 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $353.56 | 14 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $305.52 | 15 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $266.27 | 13 | $0 (2024) |
| Relypsa, Inc. | $204.15 | 11 | $0 (2020) |
| Horizon Therapeutics plc | $183.08 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,707 | 98 | Amgen Inc. ($281.86) |
| 2023 | $1,021 | 63 | OPKO Pharmaceuticals, LLC ($189.15) |
| 2022 | $583.98 | 31 | Bayer HealthCare Pharmaceuticals Inc. ($134.49) |
| 2021 | $413.00 | 30 | OPKO Pharmaceuticals, LLC ($113.63) |
| 2020 | $148.28 | 8 | Relypsa, Inc. ($54.44) |
| 2019 | $435.12 | 24 | Amgen Inc. ($117.81) |
| 2018 | $479.41 | 25 | Amgen Inc. ($166.02) |
| 2017 | $492.93 | 31 | OPKO Pharmaceuticals, LLC ($107.14) |
All Payment Transactions
310 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: Catheter Lock Solution | ||||||
| 12/10/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 12/05/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Nephrology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 12/02/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/02/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $12.01 | General |
| 11/21/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 11/13/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Nephrology | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: NEPHROLOGY | ||||||
| 11/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/14/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/14/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 10/09/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.97 | General |
| 10/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Nephrology | ||||||
| 10/07/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/03/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 09/27/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Nephrology | ||||||
| 09/03/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 868 | 2,850 | $408,667 | $223,279 |
| 2022 | 15 | 1,407 | 4,336 | $673,400 | $371,568 |
| 2021 | 19 | 978 | 2,308 | $498,339 | $270,315 |
| 2020 | 14 | 1,284 | 3,132 | $716,113 | $340,379 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 64 | 251 | $125,500 | $63,358 | 50.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 159 | 620 | $49,600 | $36,171 | 72.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 376 | $39,480 | $26,116 | 66.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 62 | 114 | $48,450 | $24,149 | 49.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 77 | 598 | $41,860 | $20,699 | 49.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 187 | $19,635 | $14,933 | 76.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 63 | 378 | $30,240 | $12,700 | 42.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 87 | 106 | $14,840 | $9,854 | 66.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 44 | 162 | $27,540 | $8,260 | 30.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 39 | $7,722 | $4,792 | 62.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $3,800 | $2,246 | 59.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 109 | 449 | $224,500 | $120,549 | 53.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 263 | 1,045 | $83,600 | $56,053 | 67.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 87 | 473 | $49,659 | $36,782 | 74.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 79 | 154 | $65,450 | $33,630 | 51.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 107 | 448 | $76,160 | $24,326 | 31.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 131 | 644 | $45,080 | $23,279 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 299 | $31,395 | $23,250 | 74.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 158 | 210 | $29,400 | $20,283 | 69.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 91 | 359 | $28,720 | $13,627 | 47.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 54 | 58 | $11,484 | $8,439 | 73.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 71 | 80 | $8,400 | $3,684 | 43.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 24 | 24 | $4,800 | $3,148 | 65.6% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 12 | 44 | $7,480 | $2,836 | 37.9% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2022 | 16 | 16 | $5,952 | $1,279 | 21.5% |
About Dr. Rafael Lopez, M.D
Dr. Rafael Lopez, M.D is a Specialist healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700890936.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rafael Lopez, M.D has received a total of $5,281 in payments from pharmaceutical and medical device companies, with $1,707 received in 2024. These payments were reported across 310 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,071).
As a Medicare-enrolled provider, Lopez has provided services to 4,537 Medicare beneficiaries, totaling 12,626 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Montgomery, AL
- Active Since 07/27/2006
- Last Updated 01/26/2026
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1700890936
Products in Payments
- RAYALDEE (Drug) $512.66
- Velphoro (Drug) $451.35
- Auryxia (Drug) $418.58
- Kerendia (Drug) $402.54
- KRYSTEXXA (Biological) $339.19
- Parsabiv (Biological) $326.52
- Veltassa (Drug) $315.89
- TARPEYO (Drug) $266.27
- JYNARQUE (Drug) $259.69
- LOKELMA (Drug) $222.01
- FARXIGA (Drug) $168.39
- Parsabiv (Drug) $143.47
- JARDIANCE (Drug) $140.35
- Aranesp (Biological) $125.75
- LUPKYNIS (Drug) $112.91
- Rayaldee (Drug) $107.14
- IBSRELA (Drug) $90.14
- Ozempic (Drug) $58.33
- DefenCath (Drug) $58.31
- ACTHAR (Biological) $55.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Montgomery
Dr. Rosa Bell, Md, MD
Specialist — Payments: $20,679
Dr. John Robertson, M.d, M.D
Specialist — Payments: $15,644
Dr. Stephen Owens, M.d, M.D
Specialist — Payments: $10,634
Dr. Patrick Budny, M.d, M.D
Specialist — Payments: $8,612
Dr. Michael Bentley, M.d, M.D
Specialist — Payments: $7,374
Timothy Morrow, M.d, M.D
Specialist — Payments: $2,741